HELMERICH HANS

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
20
Insider Sells Sum
$67.12M

Insider Activity of HELMERICH HANS

The largest sale of all time was on 2014-03-31 and amounted to 80000 shares of Helmerich & Payne, Inc. for $8.59M.

Biography of HELMERICH HANS

No biography is available at this moment.

2023-09-27SaleHelmerich & Payne, Inc.
HP
director
74,373
0.0732%
$43.65$3.25M-14.82%
2023-09-26SaleHelmerich & Payne, Inc.
HP
director
25,627
0.0258%
$42.46$1.09M-10.29%
2022-12-01SaleHelmerich & Payne, Inc.
HP
director
10,500
0.01%
$50.02$525,240-16.47%
2022-12-01SaleCoterra Energy Inc.
CTRA
director
5,000
0.0006%
$27.64$138,218-5.58%
2022-03-10SaleHelmerich & Payne, Inc.
HP
100,000
0.0943%
$42.54$4.25M+6.01%
2021-03-11SaleHelmerich & Payne, Inc.
HP
director
50,000
0.0464%
$32.76$1.64M-11.2%
2016-12-01SaleHelmerich & Payne, Inc.
HP
director
44,587
0.0405%
$76.60$3.42M-24.5%
2016-11-30SaleHelmerich & Payne, Inc.
HP
director
40,413
0.0374%
$75.75$3.06M-22.3%
2016-03-21SaleHelmerich & Payne, Inc.
HP
director
40,000
0.037%
$60.88$2.44M+8.86%
2014-03-31SaleHelmerich & Payne, Inc.
HP
director
80,000
0.0738%
$107.34$8.59M-7.95%
2014-03-14SaleHelmerich & Payne, Inc.
HP
director
80,000
0.0742%
$97.82$7.83M+3.27%
2013-09-24SaleHelmerich & Payne, Inc.
HP
CEO
100,000
0.0945%
$69.08$6.91M+49.04%
2010-12-16SaleHelmerich & Payne, Inc.
HP
President & CEO
84,000
0.0792%
$48.65$4.09M+21.1%
2009-10-16SaleHelmerich & Payne, Inc.
HP
President & CEO
90,000
0.0833%
$43.27$3.89M-9.53%
2008-06-16SaleHelmerich & Payne, Inc.
HP
President & CEO
55,000
0.0524%
$66.78$3.67M-53.88%
2008-06-13SaleHelmerich & Payne, Inc.
HP
President & CEO
65,000
0.063%
$66.62$4.33M-53.03%
2006-05-10SaleHelmerich & Payne, Inc.
HP
President & CEO
30,000
0.0282%
$78.84$2.37M-32.45%
2005-02-21SaleHelmerich & Payne, Inc.
HP
President & CEO
55,000
0.1588%
$59.79$3.29M
2005-02-11SaleHelmerich & Payne, Inc.
HP
President & CEO
34,000
0.0665%
$39.75$1.35M+34.08%
2004-03-12SaleHelmerich & Payne, Inc.
HP
President & CEO
35,000
0.0693%
$28.75$1.01M-1.68%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.